Biological Products, (No Diagnostic Substances) · DE · CIK 1326110
Develops and commercializes therapies and vaccines to activate the immune system against cancers and infectious diseases
Comparable business profile · signals at a glance
In the 90 days to Feb 24, 2026: 2 sold $4.5M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 24, 2026 | Simon Barry J.Director | Sell | 75,000 | $12.01 | $901K |
| Feb 23, 2026 | Simon Barry J.Director | Sell | 165,000 | $10.25 | $1.7M |
| Feb 23, 2026 | Selecky ChristobelDirector | Sell | 25,000 | $10.00 | $250K |
| Feb 20, 2026 | Simon Barry J.Director | Sell | 10,000 | $9.25 | $93K |
| Jan 20, 2026 | Simon Barry J.Director | Sell | 75,000 | $7.88 | $591K |
| Jan 20, 2026 | Simon Barry J.Director | Sell | 76,967 | $6.54 | $503K |
| Jan 20, 2026 | Selecky ChristobelDirector | Sell | 25,000 | $7.51 | $188K |
| Jan 16, 2026 | Selecky ChristobelDirector | Sell | 50,000 | $5.00 | $250K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗